Últimos Artículos de Diabetes, Obesity and Metabolism
- Effects of reducing sedentary behaviour on renal glucose uptake during insulin stimulation: A post‐hoc analysis of a 6‐month randomized controlled trial
- Clinical features and outcomes of diabetic ketoacidosis in patients using SGLT2 inhibitors: A systematic review and meta‐analysis
- Improved glycemic regulation on exercise compared to non‐exercise days in a real‐world setting in individuals recently diagnosed with type 2 diabetes: A secondary analysis of the MOTIVATE T2D randomised controlled trial
- A cost‐effectiveness analysis of behavioural, pharmacological, and surgical obesity treatments in Canada
- Neurobeachin (NBEA) is a novel gene associated with GLP‐1 receptor agonist associated weight loss
- Cognitive reserve, genetic risk, and lifestyle in the incidence and progression of type 2 diabetes: A large community‐based longitudinal study
- Weight reduction over time in tirzepatide‐treated participants by early weight loss response: Post hoc analysis in SURMOUNT‐1
- An overview of randomized clinical trials of fixed‐ratio combinations of basal insulin plus GLP‐1RA (injectable therapy): Lessons for advancing therapy in people with type 2 diabetes
- Initial observations on the frequency of diabetic ketoacidosis following pilot screening for type 1 diabetes in the general Italian population
- Prediction of glycaemic control and quality of life in people with type 2 diabetes using glucose‐lowering drugs with machine learning—The Maastricht study
- Cardiometabolic diseases and dynamic transitions of neuropsychiatric disorders: A longitudinal trajectory analysis
- Prevalence of SGLT2 inhibitor and GLP1 receptor agonist prescriptions in type 2 diabetes patients with and without chronic kidney disease: Analysis of an Australian primary care dataset
- Adherence to four dietary indices and the risk of all‐cause and cause‐specific dementia: Findings from the UK Biobank study
- Adherence to GLP‐1 receptor agonists and SGLT2 inhibitors by out‐of‐pocket spending among Medicare beneficiaries with diabetes
- Novel oral agents in anti‐obesity pharmacotherapy: A narrative review
- Could continuous subcutaneous glucose sensors (CGMS) be repurposed to diagnose diabetes in equivocal or challenging cases?
- Short‐term associations between metabolic heterogeneity of obesity and cognitive frailty transitions: An ongoing Chinese elderly cohort study
- First‐in‐human study of HDM1002, a GLP‐1 receptor agonist: Safety, tolerability, pharmacokinetics and pharmacodynamics of escalating single oral doses in healthy volunteers
- Cardiorenal outcomes and mortality with GLP‐1 receptor agonists combined with SGLT2 inhibitors in type 2 diabetes: An updated systematic review and meta‐analysis
- Changes in adiposity indices over 10 years and risk of type 2 diabetes: The Whitehall II cohort study